Stopped
Infections · Ulcerative Colitis/Crohn's Disease
Withdrawn before enrolling
TakedaNot specified NCT07250815 Registry history of NCT07250815 on ClinicalTrials.gov (opens the registry)
19 trials changed in the last 30 days: 1 stopped, 8 with notable changes, 10 with minor changes only.
Withdrawn before enrolling
TakedaNot specified NCT07250815 Registry history of NCT07250815 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 31, 2026 to Jun 30, 2027
TakedaNot specified NCT04961840 Registry history of NCT04961840 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Enrollment increased: 223 → 273 participants; Trial arms changed: 6 → 5
TakedaPhase 1/2 NCT07205718 Registry history of NCT07205718 on ClinicalTrials.gov (opens the registry)
Recruitment opened
Also in this update: Trial sites expanded: 0 → 3 locations
TakedaNot specified NCT07445087 Registry history of NCT07445087 on ClinicalTrials.gov (opens the registry)
Recruitment opened
Also in this update: Trial sites expanded: 0 → 10 locations
TakedaNot specified NCT07623174 Registry history of NCT07623174 on ClinicalTrials.gov (opens the registry)
Results posted: Sep 30, 2026
TakedaPhase 2/3 NCT05755035 Registry history of NCT05755035 on ClinicalTrials.gov (opens the registry)
Results posted: Oct 6, 2026
TakedaPhase 2 NCT04530123 Registry history of NCT04530123 on ClinicalTrials.gov (opens the registry)
Start date pushed from Sep 1, 2026 to Oct 15, 2026
TakedaPhase 2 NCT07613359 Registry history of NCT07613359 on ClinicalTrials.gov (opens the registry)
Results posted: Sep 25, 2026
TakedaPhase 1/2 NCT05886491 Registry history of NCT05886491 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
Also in this update: Trial sites reduced: 123 → 120 locations
TakedaPhase 3 NCT06671496 Registry history of NCT06671496 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Dec 31, 2026 to Jul 22, 2026
TakedaPhase 3 NCT06439342 Registry history of NCT06439342 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
TakedaPhase 3 NCT06579755 Registry history of NCT06579755 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 243 participants (planned 200)
TakedaPhase 4 NCT04809363 Registry history of NCT04809363 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Dec 31, 2031 to Aug 26, 2026
TakedaNot specified NCT05561647 Registry history of NCT05561647 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 160 → 210 participants
TakedaPhase 2 NCT04419649 Registry history of NCT04419649 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 56 → 65 locations
TakedaPhase 3 NCT06980480 Registry history of NCT06980480 on ClinicalTrials.gov (opens the registry)
Trial sites reduced: 54 → 47 locations
TakedaPhase 3 NCT06405087 Registry history of NCT06405087 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 177 → 182 locations
TakedaPhase 3 NCT06499285 Registry history of NCT06499285 on ClinicalTrials.gov (opens the registry)
Trial sites expanded: 190 → 201 locations
TakedaPhase 2 NCT06233461 Registry history of NCT06233461 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-13 | NCT07871721 A Study of Zasocitinib in Adults With Psoriatic Arthritis (LATITUDE PsA NeXt) | Phase 3 | Not Yet Recruiting |
| 2026-10-09 | NCT07868081 A Study to Better Understand the Diagnosis and Treatment of Polycythaemia Vera | Not Yet Recruiting | |
| 2026-10-09 | NCT07868107 A Study of Secondary Immunodeficiencies in Adults With Blood Cancers in Kazakhstan Who… | Not Yet Recruiting |
| Phase 1 | 2 | |
| Phase 1/2 | 5 | |
| Phase 2 | 19 | |
| Phase 2/3 | 3 | |
| Phase 3 | 42 | |
| Phase 4 | 7 |
Crohn's Disease (14) · Ulcerative Colitis (10) · Lung Cancer (7) · Non-Small Cell Lung Cancer (NSCLC) (7) · Psoriasis (7) · Colorectal Cancer (5) · Hodgkin Lymphoma (4) · Multiple Myeloma (4) · Myelodysplastic Syndromes (MDS) (4) · Psoriatic Arthritis (4)